EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Venous Thromboembolism in COVID-19 Patients: A Single-Center Case Series

Mohammad Sadegh Keshmiri, Babak Sharif Kashani, Sima Noorali, Somayeh Lookzadeh, Sina Aghdasi, Mahsa Riahi, Aylar Fazlzadeh, Arezoo Mohamadifar, Alireza Serati, Zargham Hossein Ahmadi, Shadi Shafaghi

International Journal of Cardiovascular Practice · 2023

DOI: 10.5812/intjcardiovascpract-133219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cardiovascular Practice, 2023. Verfasst von Mohammad Sadegh Keshmiri und 10 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: Since thrombosis occurrence among coronavirus disease 2019 (COVID-19) patients is a critical complication, this study aimed to describe the clinical characteristics and outcomes of COVID-19-associated pulmonary thromboembolism (PTE). This case series of 39 venous thromboembolism (VTE) patients represents clinical characteristics, laboratory data, imaging data, and outcomes. The mean age of the patients was 55 ± 15 years. Moreover, 25 patients (64.10%) were male. The most frequent COVID-19 clinical presentations were dyspnea and cough in 22 (56.41%) and 19 (48.71%) patients, respectively. Additionally, the most frequent PTE clinical presentations were palpitation and anxiety in 28 (71.79%) and dyspnea in 24 (61.53%) patients. Furthermore, eight patients (20.51%) showed deep vein thrombosis in color Doppler ultrasound. The mean measures of D-dimer, erythrocyte sedimentation rate and C-reactive protein were 3680 ng/mL, 53 mm/hour, and 44 mg/L, respectively. Supplemental oxygen and ventilator were required in 29 (74.35%) and 2 (5.12%) patients, respectively. One patient died from PTE complications, and others improved without any complications. The VTE is a potentially life-threatening complication that frequently occurs in patients with COVID-19. Therapeutic doses of anticoagulants, extended thromboprophylaxis, meticulous assessments, follow-up, and high clinical suspicion to the early detection of PTE are necessary in this regard.

Zitieren

APA

Keshmiri, M. S., Kashani, B. S., Noorali, S., Lookzadeh, S., Aghdasi, S., Riahi, M., Fazlzadeh, A., Mohamadifar, A., Serati, A., Ahmadi, Z. H., & Shafaghi, S. (2023). Venous Thromboembolism in COVID-19 Patients: A Single-Center Case Series. International Journal of Cardiovascular Practice. https://doi.org/10.5812/intjcardiovascpract-133219

Vancouver

Keshmiri MS, Kashani BS, Noorali S, Lookzadeh S, Aghdasi S, Riahi M, et al. Venous Thromboembolism in COVID-19 Patients: A Single-Center Case Series. International Journal of Cardiovascular Practice. 2023. doi:10.5812/intjcardiovascpract-133219

BibTeX
@article{Keshmiri2023,
  author = {Keshmiri, Mohammad Sadegh and Kashani, Babak Sharif and Noorali, Sima and Lookzadeh, Somayeh and Aghdasi, Sina and Riahi, Mahsa and Fazlzadeh, Aylar and Mohamadifar, Arezoo and Serati, Alireza and Ahmadi, Zargham Hossein and Shafaghi, Shadi},
  title = {Venous Thromboembolism in COVID-19 Patients: A Single-Center Case Series},
  journal = {International Journal of Cardiovascular Practice},
  year = {2023},
  doi = {10.5812/intjcardiovascpract-133219}
}
Kostenlos starten →